Auscandoc<p><a href="https://www.science.org/doi/10.1126/science.abp9563" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://www.</span><span class="ellipsis">science.org/doi/10.1126/scienc</span><span class="invisible">e.abp9563</span></a> “Engineered <a href="https://med-mastodon.com/tags/StaphEpidermidis" class="mention hashtag" rel="tag">#<span>StaphEpidermidis</span></a> generated <a href="https://med-mastodon.com/tags/tumor" class="mention hashtag" rel="tag">#<span>tumor</span></a>-specific <a href="https://med-mastodon.com/tags/Tcells" class="mention hashtag" rel="tag">#<span>Tcells</span></a> that infiltrated and reduced the growth of localized and metastatic <a href="https://med-mastodon.com/tags/melanoma" class="mention hashtag" rel="tag">#<span>melanoma</span></a>. In combination with immune checkpoint inhibitors, these engineered skin bacteria caused mice to reject established tumors. These findings suggest that immune responses from engineered commensals may have therapeutic potential against other tumor antigens of interest.”</p>